Chief Strategy Officer Thomas Wicks to discuss European disclosure and the data-sharing lifecycle
Jersey City, NJ – Jan. 24, 2019 – TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced that its Chief Strategy Officer, Thomas Wicks, will present at the 6th annual Clinical Trial Disclosure and Transparency conference. TrialScope is a sponsor of the event, which will be held Jan. 29-30 in Philadelphia.
On Jan. 30 at 1:45 p.m. ET, Wicks will present, “The Big Picture — How EU Regulations Impact Small to Mid-Sized Life Science Companies.” His presentation will offer:
- Challenges unique to pharmaceutical companies of this size
- An overview of EU disclosure regulations
- Explanation of what inspections entail
- The impact of transparency advocates
- Recommendations on disclosure policies and procedures
Wicks also will conduct a joint presentation with Julie Wood, Director of Strategy and Operations for Vivli. Their presentation, “The Disclosure and Data Sharing Lifecycle,” will be held at 9:30 a.m. ET Jan. 30.
“I am eager to share the latest insights on EU regulations with my colleagues,” said Wicks. “And I am particularly pleased to be diving into the topic of data sharing with Vivli. Its mission of sharing individual data from completed clinical trials dovetails with TrialScope’s goals for increased transparency in the industry.”
TrialScope is hosting an invitation-only event, “Drinks and Disclosure,” at the conclusion of the first day of the conference. For more information on the conference, including the full agenda, visit: http://www.cbinet.com/conference/pc19257
TrialScope is the global leader in clinical trial disclosure and transparency management technology, supporting 13 of the top 15 industry clinical trial sponsors worldwide. TrialScope provides proven solutions that optimize the efficiency of disclosure activities, maximize trial data transparency, and foster more informed, engaged patients through open research sharing. To learn more about TrialScope, visit TrialScope.com.